These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 11384672

  • 1. Flow cytometric quantitation of calcium-dependent and -independent mitogen-stimulation of T cell functions in whole blood: inhibition by immunosuppressive drugs in vitro.
    Barten MJ, Gummert JF, van Gelder T, Shorthouse R, Morris RE.
    J Immunol Methods; 2001 Jul 01; 253(1-2):95-112. PubMed ID: 11384672
    [Abstract] [Full Text] [Related]

  • 2. Assessment of mechanisms of action of immunosuppressive drugs using novel whole blood assays.
    Barten MJ, Gummert JF, van Gelder T, Shorthouse R, Morris RE.
    Transplant Proc; 2001 May 01; 33(3):2119-20. PubMed ID: 11377470
    [No Abstract] [Full Text] [Related]

  • 3. Baohuoside-1, a novel immunosuppressive molecule, inhibits lymphocyte activation in vitro and in vivo.
    Ma A, Qi S, Xu D, Zhang X, Daloze P, Chen H.
    Transplantation; 2004 Sep 27; 78(6):831-8. PubMed ID: 15385801
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the in vitro antiproliferative effects of five immunosuppressive drugs on lymphocytes in whole blood from cats.
    Kyles AE, Gregory CR, Craigmill AL.
    Am J Vet Res; 2000 Aug 27; 61(8):906-9. PubMed ID: 10951980
    [Abstract] [Full Text] [Related]

  • 5. Pharmacodynamics of immunosuppression by mycophenolic acid: inhibition of both lymphocyte proliferation and activation correlates with pharmacokinetics.
    Gummert JF, Barten MJ, Sherwood SW, van Gelder T, Morris RE.
    J Pharmacol Exp Ther; 1999 Dec 27; 291(3):1100-12. PubMed ID: 10565830
    [Abstract] [Full Text] [Related]

  • 6. Mechanism of the antiproliferative action of leflunomide. A77 1726, the active metabolite of leflunomide, does not block T-cell receptor-mediated signal transduction but its antiproliferative effects are antagonized by pyrimidine nucleosides.
    Cao WW, Kao PN, Chao AC, Gardner P, Ng J, Morris RE.
    J Heart Lung Transplant; 1995 Dec 27; 14(6 Pt 1):1016-30. PubMed ID: 8719445
    [Abstract] [Full Text] [Related]

  • 7. Flow cytometric analysis of the molecular mechanisms of immunosuppressive action of the active metabolite of leflunomide and its malononitrilamide analogues in a novel whole blood assay.
    Slauson SD, Silva HT, Sherwood SW, Morris RE.
    Immunol Lett; 1999 Apr 15; 67(3):179-83. PubMed ID: 10369124
    [Abstract] [Full Text] [Related]

  • 8. Opposing effects of rapamycin and cyclosporin A on activation-induced Ca(2+) release.
    Almawi WY, Assi JW, Chudzik DM, Lazarovits AI.
    Eur J Pharmacol; 1999 Sep 17; 381(1):51-6. PubMed ID: 10528133
    [Abstract] [Full Text] [Related]

  • 9. In-vitro immunosuppression of canine T-lymphocyte-specific proliferation with dexamethasone, cyclosporine, and the active metabolites of azathioprine and leflunomide in a flow-cytometric assay.
    Nafe LA, Dodam JR, Reinero CR.
    Can J Vet Res; 2014 Jul 17; 78(3):168-75. PubMed ID: 24982547
    [Abstract] [Full Text] [Related]

  • 10. Coexpression of CD4 and CD8alpha on rat T-cells in whole blood: a sensitive marker for monitoring T-cell immunosuppressive drugs.
    Diaz-Romero J, Vogt G, Weckbecker G.
    J Immunol Methods; 2001 Aug 01; 254(1-2):1-12. PubMed ID: 11406149
    [Abstract] [Full Text] [Related]

  • 11. Novel assays of multiple lymphocyte functions in whole blood measure: new mechanisms of action of mycophenolate mofetil in vivo.
    Barten MJ, van Gelder T, Gummert JF, Shorthouse R, Morris RE.
    Transpl Immunol; 2002 Jun 01; 10(1):1-14. PubMed ID: 12182459
    [Abstract] [Full Text] [Related]

  • 12. Increase of intracellular calcium is the essential signal for the expression of CD40 ligand.
    Nüsslein HG, Frosch KH, Woith W, Lane P, Kalden JR, Manger B.
    Eur J Immunol; 1996 Apr 01; 26(4):846-50. PubMed ID: 8625977
    [Abstract] [Full Text] [Related]

  • 13. Synergistic effects of sirolimus with cyclosporine and tacrolimus: analysis of immunosuppression on lymphocyte proliferation and activation in rat whole blood.
    Barten MJ, Streit F, Boeger M, Dhein S, Tarnok A, Shipkova M, Armstrong VW, Mohr FW, Oellerich M, Gummert JF.
    Transplantation; 2004 Apr 27; 77(8):1154-62. PubMed ID: 15114077
    [Abstract] [Full Text] [Related]

  • 14. Validation of immunological biomarkers for the pharmacodynamic monitoring of immunosuppressive drugs in humans.
    Böhler T, Nolting J, Kamar N, Gurragchaa P, Reisener K, Glander P, Neumayer HH, Budde K, Klupp J.
    Ther Drug Monit; 2007 Feb 27; 29(1):77-86. PubMed ID: 17304154
    [Abstract] [Full Text] [Related]

  • 15. Signals involved in T cell activation. I. Phorbol esters enhance responsiveness but cannot replace intact accessory cells in the induction of mitogen-stimulated T cell proliferation.
    Davis L, Lipsky PE.
    J Immunol; 1985 Nov 27; 135(5):2946-52. PubMed ID: 3876369
    [Abstract] [Full Text] [Related]

  • 16. Differential regulation by dexamethasone and cyclosporine of human T cells activated by various stimuli.
    Furue M, Ishibashi Y.
    Transplantation; 1991 Sep 27; 52(3):522-6. PubMed ID: 1654606
    [Abstract] [Full Text] [Related]

  • 17. The anti-inflammatory effect of the SOCC blocker SK&F 96365 on mouse lymphocytes after stimulation by Con A or PMA/ionomycin.
    Ye Y, Zhang Y, Lu X, Huang X, Zeng X, Lai X, Zeng Y.
    Immunobiology; 2011 Sep 27; 216(9):1044-53. PubMed ID: 21470712
    [Abstract] [Full Text] [Related]

  • 18. Plant alkaloid tetrandrine and its analog block CD28-costimulated activities of human peripheral blood T cells: potential immunosuppressants in transplantation immunology.
    Lai JH, Ho LJ, Kwan CY, Chang DM, Lee TC.
    Transplantation; 1999 Nov 15; 68(9):1383-92. PubMed ID: 10573080
    [Abstract] [Full Text] [Related]

  • 19. Differential inhibition of the T cell activation pathway by dexamethasone and cyclosporine.
    Furue M, Kawakami Y, Kawakami T, Katz SI.
    Transplantation; 1990 Mar 15; 49(3):560-4. PubMed ID: 2156362
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of anti-CD3 antibody-induced mouse T cell activation by pentoxifylline in combination with rapamycin or A77 1726 (leflunomide).
    Richard M, Hoskin DW.
    Int J Immunopharmacol; 1998 Mar 15; 20(4-5):241-52. PubMed ID: 9730259
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.